🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The study is designed to test whether or not the rate and extent of absorpt...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2012-09
Trial ID
NCT01677039
Title of Study: An Open-Label, Balanced, Randomized, 2-Treatment, 2-Sequenc...
Status
Completed
Location
Algorithme Pharma Inc.
Start Date
2015-10-29
Trial ID
NCT05145621
Treatments Being Tested
Bioavailability is the extent and rate to which the active drug ingredient ...
Status
Unknown
Location
Department of Pharmacy, Kathmandu University
Start Date
2023-08-06
Trial ID
NCT05641649
Treatments Being Tested
Cefixime is an orally active third generation cephalosporin indicated for t...
Status
Withdrawn
Location
Multiple Locations
Start Date
2018-01-11
Trial ID
NCT03329547
Treatments Being Tested
The primary objective of this study is to assess the pharmacokinetic profil...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-01-20
Trial ID
NCT00938275
Treatments Being Tested
The main objectives of this trial are to investigate pharmacokinetics (PK) ...
Status
Completed
Location
SOUSEIKAI Sumida Hospital
Start Date
2023-12-20
Trial ID
NCT06139302
Treatments Being Tested
The goal of this double-blind, placebo-controlled randomized clinical trial...
Status
Recruiting
Location
Yale School of Medicine
Start Date
2024-06-01
Trial ID
NCT06191965
This proof of principle study will evaluate an experimental formulation of ...
Status
Completed
Location
Charles River Clinical Services Northwest, Inc.
Start Date
2010-05
Trial ID
NCT01551797
Treatments Being Tested
The objective of this study was to evaluate and compare the bioavailability...
Status
Completed
Location
Algorithme Pharma
Start Date
2017-10-22
Trial ID
NCT05549570
Treatments Being Tested
Objectives: The objectives of the study was to investigate the bioequivale...
Status
Completed
Location
CROSS Research S.A., Phase I Unit
Start Date
2016-07-04
Trial ID
NCT02858193
Treatments Being Tested